Anna Simonetto, R&D Researcher at Dipharma, Selected as Speaker at EWOC Europe 2026
Panel discussion on Custom synthesis & Contract manufacturing
LETERMOVIR
Therapeutic class: Antiviral CAS number: 917389-32-3 Regulatory status: [...]
ETRIPAMIL
Therapeutic class: Antiarrhythmic Agent CAS number: 1593673-23-4 Regulatory status: [...]
BUPROPION HBr
Therapeutic class: Antidepressant CAS number: 905818-69-1 Regulatory status: - [...]
24/7 Biopharma interviews Roberto Fanelli, Catalogue APIs BU Leader
Panel discussion on Custom synthesis & Contract manufacturing
Dipharma contributed to the PhD course “Process Development for the Synthesis of Pharmaceutical Products”
Panel discussion on Custom synthesis & Contract manufacturing
Dipharma at “The industrial process of drug discovery and development” workshop
Panel discussion on Custom synthesis & Contract manufacturing
Dipharma publishes a peer-reviewed study in OPR&D: a novel approach to detect and characterize nitrosamine formation in APIs
Panel discussion on Custom synthesis & Contract manufacturing
Dipharma flow chemistry lecture at the “Technology-Driven Organic Synthesis” course
Panel discussion on Custom synthesis & Contract manufacturing
Dipharma’s Caronno Pertusella site has successfully renewed its CBPF certification
Panel discussion on Custom synthesis & Contract manufacturing
